TrialInflammatory bowel diseases2021

Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies.

William J Sandborn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.